Potential anatomical predictors of in-hospital complications following transfemoral aortic valve replacement with the MedInzh prosthesis: a pilot study

Until recently, the only transcatheter synthetic aortic prostheses available on the Russian market were those with transapical or transaortic delivery systems. A synthetic prosthesis with a novel transfemoral delivery system has been developed in our country; however, the literature contains no data on the results of its use.

Aim: To assess the incidence of in-hospital complications in the early postoperative period following transcatheter aortic valve replacement (TAVR) with the MedInzh prosthesis in patients with degenerative aortic valve stenosis, based on multislice computed tomography (panaortography) data (MSCT), and to identify their potential anatomical predictors.

Material and methods. This clinical trial is a prospective, single-center pilot study included patients with confirmed severe aortic stenosis: effective aortic valve orifice area of ≤ 1.0 cm²; mean transvalvular gradient ≥ 40 mmHg. All patients underwent transfemoral valve replacement for correction of severe degenerative aortic stenosis using the synthetic MedInzh prosthesis. All procedures were performed between 2023 and 2025.

Results. A total of 30 patients at moderate and high surgical risk were enrolled; median age was 75 (68.5; 77.5) years; 27% were male. The incidence of in-hospital complications was 27% (acute cerebrovascular accident 7%; ventricular arrhythmias 7%; acute common iliac artery thrombosis 7%; acute myocardial ischemia 3%; lymphocele 3%). The odds of complications after TAVR increased when the minimal diameter of the common iliac artery on the access side was ≤ 10.5 mm (OR = 19.2; 95% CI: 1.844–199.9); with the longitudinal diameter of the external iliac artery was ≤ 7.75 mm (OR = 25.5; 95% CI: 2.5–276); and with a transverse diameter was ≤ 8.2 mm (OR = 8; 95% CI: 1.2–55).

Conclusions. Among intermediate- and high-risk patients with severe symptomatic aortic stenosis undergoing transfemoral aortic valve replacement with the MedInzh prosthesis, the rate of in-hospital complications was 27%, with vascular complications accounting for 7%. MSCT panaortography results suggest that the diameter of the common iliac arteries, the minimal diameter of the common iliac artery, and the longitudinal and transverse diameters of the external iliac arteries on the access side are potential anatomical predictors associated with the development of vascular complications after TAVR.

1. Otto C.M., Nishimura R.A., Bonow R.O. et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35–e71. DOI: 10.1161/CIR.0000000000000932

2. Carroll J.D., Mack M.J., Vemulapalli S., et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. Ann. Thorac. Surg. 2021;111(2):701–722. DOI: 10.1016/j.athoracsur.2020.09.002

3. Zaid S., Atkins M.D., Kleiman N.S., et al. What's New with TAVR? An Update on Device Technology. Methodist Debakey Cardiovasc. J. 2023;19(3):4–14. DOI: 10.14797/mdcvj.1230

4. Gonska B., Reuter C., Mörike J. et al. Vascular access site complications do not correlate with large sheath diameter in TAVI procedures with new generation devices. Front. Cardiovasc. Med. 2021;8:738854. DOI: 10.3389/fcvm.2021.738854

5. Carroll J.D., Mack M.J., Vemulapalli S., et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J. Am. Coll Cardiol. 2020;76(21):2492–2516. DOI: 10.1016/j.jacc.2020.09.595

6. Fonseca P., Almeida J., Bettencourt N., et al. Incidence and predictors of vascular access site complications following transfemoral transcatheter aortic valve implantation. Rev. Port. Cardiol. 2017;36(10):747–753. English, Portuguese. DOI: 10.1016/j.repc.2015.11.009

7. Cannata S., Gandolfo C., Ribichini F.L. et al. One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry. EuroIntervention. 2023;18(17):1418. DOI: 10.4244/EIJ-D-22-01022 EDN: CSNQSY

8. Богачев-Прокофьев А.В., Шарифулин Р.М., Зубарев Д.Д., Караськов А.М. Первый опыт имплантации транскатетерного протеза аортального клапана «МедЛаб-КТ». Российский кардиологический журнал. 2018;(11):50–56. DOI: 10.15829/1560-4071-2018-11-50-56

9. Hayashida K., Lefèvre T., Chevalier B., et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc. Interv. 2011;4(8):851–858. DOI: 10.1016/j.jcin.2011.03.019

10. Staudacher D.L., Braxmeier K., Stachon P., et al. Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications. Catheter Cardiovasc. Interv. 2021;98(6):E947–E953. DOI: 10.1002/ccd.29885

11. Reinthaler M., Aggarwal S.K., De Palma R., et al. Anatol. J. Cardiol. 2015 Apr;15(4):297–305. DOI: 10.5152/akd.2014.5311

12. Aktan A., Demir M., Güzel T., et al. The effect of aortic angulation on clinical outcomes of patients undergoing transcatheter aortic valve replacement. Braz. J. Cardiovasc. Surg. 2024;39(2):e20220436. DOI: 10.21470/1678-9741-2022-0436

13. Aslan S., Türkvatan A., Güner A., et al. Effect of aortic angulation on outcomes in transcatheter aortic valve implantation with the self-expanding portico valve. Koşuyolu Heart J. 2022;25(2):132–140. DOI: 10.51645/khj.2022.m244

14. Khalefa B.B., Gonnah A.R., Yassin M.N.A., et al. Impact of aortic angulation on outcomes in transcatheter aortic valve replacement with balloon-expandable and self-expanding valves: a systematic review and meta-analysis. Cardiovasc. Interv. Ther. 2025;40(4):746–766. DOI: 10.1007/s12928-025-01169-8